# OnCo record eortc-1607-pembro-cisgem (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/eortc-1607-pembro-cisgem/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "eortc-1607-pembro-cisgem", "NCT03260712" ;
  schema:name "EORTC 1607: pembrolizumab with cisplatin and gemcitabine in biliary tract cancer"@en ;
  schema:alternateName "EORTC-1607"@en ;
  schema:description "A 50-patient European single-arm study that added pembrolizumab to standard chemotherapy for bile duct and gallbladder cancer at sites including three in England, run before the large KEYNOTE-966 trial reported."@en ;
  schema:url <https://onco.cc/trials/eortc-1607-pembro-cisgem/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03260712> ;
  onco:status "completed" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/gallbladder/>, <https://onco.cc/cancers/cholangiocarcinoma/>, <https://onco.cc/cancers/biliary-tract-cancer/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/platinum/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/gemcitabine-cisplatin/>, <https://onco.cc/drugs/gemcitabine/>, <https://onco.cc/drugs/cisplatin/> .